A Alivus Life Sciences Limited: directors' dealings · India · SEBI (PIT + SAST) SEBI:alivus-life-sciences-limited IN IN · SEBI (PIT + SAST)
Explore the full management transaction log of Alivus Life Sciences Limited, a listed issuer based in India. Shares trade on IN IN, under the supervision of SEBI (PIT + SAST). The latest transaction was disclosed on 15 July 2024 (Sale). Among the most active insiders: GLENN SALDANHA. All data is free.
Last declaration on 15 July 2024
Declarations 8 total
Executives ● Sale0 SEBI
€88m 9,609,571 shares @ €9.1389
Equity Shares
SEBI:2c31a04572c81e5986c1ab15a86149561a79c127 · 11 Jul 2024
Executives ● Sale0 SEBI
€71,188 7,800 shares @ €9.1267
Equity Shares
SEBI:8571841e409214e686dc31c1e3d5ec7c00fab77a · 11 Jul 2024
Executives ● Sale0 SEBI
€162m 24,505,435 shares @ €6.603
Equity Shares
SEBI:e50275fe84a87e25976ef64aa45f049062faa22b · 12 Mar 2024
Executives ● Purchase0 SEBI
€162m 24,505,435 shares @ €6.6097
Equity Shares
SEBI:8f6d214ad6b87762efce05e5290938c8dc4c4fd9 · 12 Mar 2024
Ideal exit: 7 Dec 2024 (T+270) Executives ● Sale0 SEBI
€447m 67,389,944 shares @ €6.6383
Equity Shares
SEBI:7a6580285e4ab87778892b1e6940df5b0906ece1 · 6 Mar 2024
Executives ● Pledge0 SEBI
€67m 9,609,571 shares @ €6.9563
Equity Shares
SEBI:a028b009998f2b6cd0e9f0078c26b6d97e983bed · 21 Sept 2023
Executives ● Purchase0 SEBI
€56,999 7,505 shares @ €7.5948
Equity Shares
SEBI:fedd2ab7716e5bbf7ff3bd5029db25fa1e9c7990 · 16 Nov 2021
Ideal exit: 13 Aug 2022 (T+270) Executives ● Purchase0 SEBI
€2,218 295 shares @ €7.5187
Equity Shares
SEBI:a844d425e971878fa72024c1c608c4095f1c4b27 · 15 Nov 2021
Ideal exit: 12 Aug 2022 (T+270)